Osteoporosis post-menopausal and Skin - clammy

Summary:

Skin - clammy is found among people with Osteoporosis post-menopausal, especially for people who are female, 60+ old.

The study analyzes which people have Skin - clammy with Osteoporosis post-menopausal. It is created by eHealthMe based on reports of 30 people who have Osteoporosis post-menopausal from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

30 people who have Osteoporosis Post-Menopausal and Skin - Clammy are studied.


What is Osteoporosis post-menopausal?

Osteoporosis post-menopausal (weak bone with possibility to break after stopped menstrual cycles) is found to be associated with 244 drugs and 100 conditions by eHealthMe.

What is Skin - clammy?

Skin - clammy is found to be associated with 2,099 drugs and 1,585 conditions by eHealthMe.

Number of Skin - clammy in Osteoporosis post-menopausal reports submitted per year:

Would you have Skin - clammy when you have Osteoporosis post-menopausal?

Gender of people who have Osteoporosis Post-Menopausal and experienced Skin - Clammy *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Osteoporosis Post-Menopausal and experienced Skin - Clammy *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 3.85 %
  • 50-59: 11.54 %
  • 60+: 84.62 %

Common co-existing conditions for these people *:

  1. Stress And Anxiety: 1 person, 3.33%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 3.33%
  3. Pain: 1 person, 3.33%
  4. Osteoporosis (bones weak and more likely to break): 1 person, 3.33%
  5. Dry Eyes (lack of adequate tears): 1 person, 3.33%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 3.33%
  7. Arrhythmias (irregular heartbeat): 1 person, 3.33%

Common drugs taken by these people *:

  1. Prolia: 17 people, 56.67%
  2. Tymlos: 10 people, 33.33%
  3. Lisinopril: 3 people, 10.00%
  4. Zocor: 3 people, 10.00%
  5. Dexilant: 3 people, 10.00%
  6. Vitamin B12: 3 people, 10.00%
  7. Potassium: 3 people, 10.00%
  8. Prevacid: 3 people, 10.00%
  9. Actonel: 2 people, 6.67%
  10. Septra: 2 people, 6.67%

Common symptoms for these people *:

  1. Dizziness: 16 people, 53.33%
  2. Nausea (feeling of having an urge to vomit): 9 people, 30.00%
  3. Feeling Hot: 8 people, 26.67%
  4. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 7 people, 23.33%
  5. Feeling Abnormal: 6 people, 20.00%
  6. Hypotension (abnormally low blood pressure): 5 people, 16.67%
  7. Breathing Difficulty: 5 people, 16.67%
  8. Diarrhea: 5 people, 16.67%
  9. Weakness: 5 people, 16.67%
  10. Back Pain: 4 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Skin - clammy?

Check whether Skin - clammy is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Skin - clammy:

Common drugs associated with Skin - clammy:

All the drugs that are associated with Skin - clammy:

Common conditions associated with Skin - clammy:

All the conditions that are associated with Skin - clammy:

How the study uses the data?

The study is based on Skin - clammy and Osteoporosis post-menopausal, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: